Both EBV and CMV induce strong CD8+ T cell responses, but whereas control of CMV is unaffected, CLL patients experience an increased frequency of subclinical reactivations.23–28. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.